As of November 2024 Prelude Therapeutics Incorporated has 0 shares outstanding, a of - from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2022 | 47.37M | 2.87% |
2021 | 46.05M | 269.03% |
2020 | 12.48M | - |